(Q34516553)

2 August 2017

1 reference

title

Effect of a US National Institutes of Health programme of clinical trials on public health and costs (English)

1 reference

2 August 2017

0 references

1

S Claiborne Johnston

1 reference

2 August 2017

John D Rootenberg

2

1 reference

2 August 2017

Shereen Katrak

series ordinal

3

1 reference

2 August 2017

Wade S Smith

series ordinal

4

1 reference

2 August 2017

Jacob S Elkins

series ordinal

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

367

1 reference

2 August 2017

issue

9519

1 reference

2 August 2017

page(s)

1319-1327

1 reference

Federal funding for biomedical research: commitment and benefits.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

A political attack on peer review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

NIH funding: a roller coaster Ride? Priorities if NIH funding increases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Setting priorities for research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Payback arising from research funding: evaluation of the Arthritis Research Campaign

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Is technological change in medicine worth it?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

A comparison of rectal diazepam gel and placebo for acute repetitive seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

A double-blind, placebo-controlled study of remacemide hydrochloride in patients with refractory epilepsy following pre-surgical assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Randomized trial of pallidotomy versus medical therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Valproate therapy for prevention of posttraumatic seizures: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Discectomy strategies for lumbar disc herniation: results of the LAPDOG trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Cost-effectiveness of prophylactic indomethacin in very-low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

The epidemiology of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Multistate utilization, processes, and outcomes of carotid endarterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Cost-effectiveness of carotid endarterectomy in asymptomatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

The underutilization of cardiac medications of proven benefit, 1990 to 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Revisiting the Appropriateness of Carotid Endarterectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Treating repetitive seizures with a rectal diazepam formulation: a randomized study. The North American Diastat Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Does willingness to pay per quality-adjusted life year bring us closer to a useful decision rule for cost-effectiveness analysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Perspectives on the pharmaceutical industry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Shattuck lecture--clinical research to clinical practice--lost in translation?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Quality of systematic reviews of economic evaluations in health care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

Making economic evaluations respectable

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968578-4

7 January 2021

10.1016/S0140-6736(06)68578-4

Identifiers

DOI

1 reference

2 August 2017

1 reference